team_name,design_id,delta_g,contacts,dockq,iface_plddt,ipsae,cdr_sasa,netsolp,cdr3_identity,anarci_pass,delta_g_score,contacts_score,dockq_score,ipsae_score,iface_plddt_score,cdr_sasa_score,netsolp_score,novelty_score,binding_struct_score,developability_score,novelty_category_score,final_score_10,final_score_100,is_viable,fail_reason
TEAM_Diagnobac_Challenge1,Pembrolizumab_5GGS,-21.4,245,1.0,0.0,0.710564,6125.0,0.5346402,100.0,True,10.0,10.0,10.0,6.211279999999999,0.0,10.0,4.692804000000001,0.0,7.70188,4.692804000000001,0.0,5.5596888,55.596888,False,CDR3 identity >= 95 percent
